Clinical Decision-Making for Drug-Resistant TB Course in Belgium 2026-2027
Applicant criteria
- NationalityNo specific nationality required
- Age13 - 60
- GenderBoth
Opportunity criteria
- Job locationBelgium
- Deadline2026-12-01
Opportunity description
The Clinical Decision-Making for Drug-Resistant Tuberculosis course offers interdisciplinary, interactive training in diagnosing and treating drug-resistant TB and making clinical decisions about care. The 2026-2027 course combines online learning with on-campus training in Antwerp, Belgium. Applications close on 1 December 2026 at 23:59 CET.
About the Drug-Resistant Tuberculosis Clinical Decision-Making Course
The course is delivered in two consecutive stages: ten weeks of online training followed by two weeks of on-campus training. This blended format combines distance learning with face-to-face study. The published information does not provide a more detailed weekly timetable or describe how activities are divided between the two stages.
Training focuses on three connected areas: the diagnosis of drug-resistant tuberculosis, its treatment, and clinical decision-making. The course is described as both interactive and interdisciplinary. It runs from 1 March 2027 to 4 June 2027 and is taught in English. The course carries five European Credit Transfer and Accumulation System credits (ECTS).
Applicants considering other learning options can browse training courses and workshops or explore other opportunities for youth.
Who Should Apply
This course may suit people seeking focused, interactive training on the clinical aspects of drug-resistant tuberculosis, including diagnosis, treatment, and clinical decision-making. The announcement does not specify educational qualifications, prior experience, or nationality requirements. Prospective applicants should consult the official course page for the available application information.
Key Highlights
- Format: ten weeks of online training followed by two weeks on campus.
- On-campus location: Antwerp, Belgium.
- Course dates: 1 March to 4 June 2027.
- Language: English.
- Credits: five ECTS.
- Application deadline: 1 December 2026 at 23:59 CET.
Benefits
The training course offers the following academic and professional benefits:
Gain advanced knowledge of the diagnosis and treatment of drug-resistant tuberculosis (TB).
Develop evidence-based clinical decision-making skills.
Learn about modern molecular tests used to diagnose drug resistance.
Improve the ability to interpret laboratory test results and select appropriate treatments.
Examine complex clinical cases and discuss them with international experts.
Learn about treatment monitoring methods and the management of side effects.
Exchange knowledge and experiences with physicians and specialists from different countries.
Earn 5 European Credit Transfer and Accumulation System (ECTS) credits upon successfully meeting the course requirements.
Benefit from a course accredited by the TropEd Network, with accreditation valid until May 31, 2028.
Eligibility criteria
According to the official website of the Institute of Tropical Medicine, applicants must meet the following eligibility requirements:
Applicants must be healthcare professionals directly involved in the clinical care of tuberculosis (TB) patients, particularly those with drug-resistant tuberculosis.
Have professional experience related to the diagnosis or treatment of drug-resistant tuberculosis.
Demonstrate English language proficiency at a high B2 or C1 level according to the Common European Framework of Reference for Languages (CEFR).
Provide proof of English language proficiency, such as an IELTS score of 6.5, a TOEFL iBT certificate, or another recognized test accepted by the institute.
Have access to a computer and an internet connection to participate in online training.
Submit a CV outlining academic qualifications and professional experience.
Submit a motivation letter describing the challenges faced in caring for patients with drug-resistant tuberculosis and the level of support provided by the applicant's institution.
Submit a written description of a case or challenge related to the diagnosis or treatment of drug-resistant tuberculosis.
Ready to apply?
Clinical Decision-Making for Drug-Resistant TB Course in Belgium 2026-2027